Tilman Schöning
Impact in
-
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
Papers in
- Oncology 5
- Peptidase Inhibition and Analysis 1
- Cancer Treatment and Pharmacology 1
- Colorectal Cancer Treatments and Studies 1
- Cancer-related Molecular Pathways 1
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Uwe Haberkorn (1 shared paper)Michael Eisenhut (1 shared paper)Ralf Jesenofsky (1 shared paper)Anthony D. Ho (4 shared papers)Annette Altmann (1 shared paper)Annette Markert (1 shared paper)Vasileios Askoxylakis (1 shared paper)Peter Dreger (2 shared papers)
- Journals
- BMC Cancer (2 papers)Annals of Hematology (1 paper)Frontiers in Oncology (1 paper)Journal of Nuclear Medicine (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
Tilman Schöning
8 papers receiving 132 citations
Peers
Comparison fields: 5 of 33
- Oncology 64
- Hematology 17
- Genetics 35
- Infectious Diseases 23
- Parasitology 8
Countries citing papers authored by Tilman Schöning
This map shows the geographic impact of Tilman Schöning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Schöning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Schöning more than expected).
Fields of papers citing papers by Tilman Schöning
This network shows the impact of papers produced by Tilman Schöning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Schöning. The network helps show where Tilman Schöning may publish in the future.
Co-authors
The 25 scholars most cited alongside Tilman Schöning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 40 | |
| 2 | 2020 | 32 | |
| 3 | 2012 | 32 | |
| 4 | 2015 | 13 | |
| 5 | 2016 | 8 | |
| 6 | 2014 | 8 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2015 | 0 |
About Tilman Schöning
Tilman Schöning is a scholar working on Oncology, Pathology and Forensic Medicine, Hematology, Molecular Biology and Genetics, having authored 9 papers that have together received 135 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Peptidase Inhibition and Analysis (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Cancer Treatment and Pharmacology (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Oncology (64 citations), Hematology (17 citations), Genetics (35 citations), Infectious Diseases (23 citations) and Parasitology (8 citations). Tilman Schöning has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Uwe Haberkorn, Michael Eisenhut, Ralf Jesenofsky, Anthony D. Ho, Annette Altmann, Annette Markert, Vasileios Askoxylakis, Peter Dreger, Thomas Luft and Mathias Witzens‐Harig. Their work appears in journals such as BMC Cancer, Annals of Hematology, Frontiers in Oncology, Journal of Nuclear Medicine and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.